ACE2 and COVID-19: IL-6 increases the severity of COVID-19 by rearranging the angiotensin-converting enzyme (ACE2) receptors and inducing macrophage cathepsin L. Cathepsin L of macrophage cleaves the S1 subunit of the coronavirus spike glycoprotein.